Multivariate exponential regression models on the rate of relapse
| . | Rate ratio . | 95% CI . | P . | |
|---|---|---|---|---|
| Age 50-60 y | 0.41 | 0.20 | 0.86 | .02 |
| Age ≥60 y | 0.27 | 0.15 | 0.49 | <.001 |
| dPCR positivity | 2.13 | 1.15 | 3.94 | .02 |
| Time from imatinib start to first U-DMR evaluation | 0.99 | 0.98 | 1.00 | .11 |
| Duration of previous imatinib treatment | 1.00 | 0.99 | 1.02 | .78 |
| . | Rate ratio . | 95% CI . | P . | |
|---|---|---|---|---|
| Age 50-60 y | 0.41 | 0.20 | 0.86 | .02 |
| Age ≥60 y | 0.27 | 0.15 | 0.49 | <.001 |
| dPCR positivity | 2.13 | 1.15 | 3.94 | .02 |
| Time from imatinib start to first U-DMR evaluation | 0.99 | 0.98 | 1.00 | .11 |
| Duration of previous imatinib treatment | 1.00 | 0.99 | 1.02 | .78 |
Statistically significant parameters are indicated in boldface type.